Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

1,908 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
The anthraquinone derivative Emodin ameliorates neurobehavioral deficits of a rodent model for schizophrenia.
Mizuno M, Kawamura H, Takei N, Nawa H. Mizuno M, et al. J Neural Transm (Vienna). 2008;115(3):521-30. doi: 10.1007/s00702-007-0867-5. Epub 2008 Feb 26. J Neural Transm (Vienna). 2008. PMID: 18301953
Pathological Implications of Oxidative Stress in Patients and Animal Models with Schizophrenia: The Role of Epidermal Growth Factor Receptor Signaling.
Nagano T, Mizuno M, Morita K, Nawa H. Nagano T, et al. Among authors: mizuno m. Curr Top Behav Neurosci. 2016;29:429-446. doi: 10.1007/7854_2015_399. Curr Top Behav Neurosci. 2016. PMID: 26475158
Neurobehavioral deficits of epidermal growth factor-overexpressing transgenic mice: impact on dopamine metabolism.
Eda T, Mizuno M, Araki K, Iwakura Y, Namba H, Sotoyama H, Kakita A, Takahashi H, Satoh H, Chan SY, Nawa H. Eda T, et al. Among authors: mizuno m. Neurosci Lett. 2013 Jun 28;547:21-5. doi: 10.1016/j.neulet.2013.04.055. Epub 2013 May 10. Neurosci Lett. 2013. PMID: 23669645
Pallidal hyperdopaminergic innervation underlying D2 receptor-dependent behavioral deficits in the schizophrenia animal model established by EGF.
Sotoyama H, Zheng Y, Iwakura Y, Mizuno M, Aizawa M, Shcherbakova K, Wang R, Namba H, Nawa H. Sotoyama H, et al. Among authors: mizuno m. PLoS One. 2011;6(10):e25831. doi: 10.1371/journal.pone.0025831. Epub 2011 Oct 12. PLoS One. 2011. PMID: 22022452 Free PMC article.
Antipsychotic potential of quinazoline ErbB1 inhibitors in a schizophrenia model established with neonatal hippocampal lesioning.
Mizuno M, Iwakura Y, Shibuya M, Zheng Y, Eda T, Kato T, Takasu Y, Nawa H. Mizuno M, et al. J Pharmacol Sci. 2010;114(3):320-31. doi: 10.1254/jphs.10099fp. Epub 2010 Oct 14. J Pharmacol Sci. 2010. PMID: 20962455
The anthraquinone derivative emodin attenuates methamphetamine-induced hyperlocomotion and startle response in rats.
Mizuno M, Kawamura H, Ishizuka Y, Sotoyama H, Nawa H. Mizuno M, et al. Pharmacol Biochem Behav. 2010 Dec;97(2):392-8. doi: 10.1016/j.pbb.2010.09.009. Epub 2010 Sep 21. Pharmacol Biochem Behav. 2010. PMID: 20863847
Common behavioral influences of the ErbB1 ligands transforming growth factor alpha and epiregulin administered to mouse neonates.
Tsuda N, Mizuno M, Yamanaka T, Komurasaki T, Yoshimoto M, Nawa H. Tsuda N, et al. Among authors: mizuno m. Brain Dev. 2008 Sep;30(8):533-43. doi: 10.1016/j.braindev.2008.01.006. Epub 2008 Mar 4. Brain Dev. 2008. PMID: 18313247
A cyclooxygenase-2 inhibitor ameliorates behavioral impairments induced by striatal administration of epidermal growth factor.
Mizuno M, Sotoyama H, Narita E, Kawamura H, Namba H, Zheng Y, Eda T, Nawa H. Mizuno M, et al. J Neurosci. 2007 Sep 19;27(38):10116-27. doi: 10.1523/JNEUROSCI.2368-07.2007. J Neurosci. 2007. PMID: 17881518 Free PMC article.
Sustained brain-derived neurotrophic factor up-regulation and sensorimotor gating abnormality induced by postnatal exposure to phencyclidine: comparison with adult treatment.
Takahashi M, Kakita A, Futamura T, Watanabe Y, Mizuno M, Sakimura K, Castren E, Nabeshima T, Someya T, Nawa H. Takahashi M, et al. Among authors: mizuno m. J Neurochem. 2006 Nov;99(3):770-80. doi: 10.1111/j.1471-4159.2006.04106.x. Epub 2006 Aug 11. J Neurochem. 2006. PMID: 16903871
Distinct influences of neonatal epidermal growth factor challenge on adult neurobehavioral traits in four mouse strains.
Tohmi M, Tsuda N, Mizuno M, Takei N, Frankland PW, Nawa H. Tohmi M, et al. Among authors: mizuno m. Behav Genet. 2005 Sep;35(5):615-29. doi: 10.1007/s10519-005-5357-7. Behav Genet. 2005. PMID: 16184489
1,908 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page